Cerity Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
18,668
-2,816
-13% -$341K ﹤0.01% 1597
2026
Q1
$3.51M Buy
21,484
+2,085
+11% +$321K 0.01% 1176
2025
Q4
$3.38M Sell
19,399
-1,962
-9% -$358K ﹤0.01% 1111
2025
Q3
$3.08M Sell
21,361
-6,780
-24% -$831K 0.01% 1093
2025
Q2
$2.83M Sell
28,141
-3,297
-10% -$252K 0.01% 1059
2025
Q1
$2.4M Buy
31,438
+13,180
+72% +$1.01M ﹤0.01% 1029
2024
Q4
$1.33M Sell
18,258
-3,090
-14% -$223K ﹤0.01% 1287
2024
Q3
$1.56M Buy
21,348
+17,869
+514% +$1.32M ﹤0.01% 1203
2024
Q2
$233K Buy
+3,479
New +$135K ﹤0.01% 1953

Other funds holding INSM

Cerity Partners's INSM Position: Q2 2026 in Review

Cerity Partners reduced its Insmed (INSM) stake by 13% in Q2 2026, selling an estimated $341K and leaving 18,668 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Cerity Partners first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.51M in Q1 2026. 609 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Cerity Partners held 18,668 shares of Insmed worth $1.99M as of Q2 2026.
  • Cerity Partners sold 2,816 Insmed shares in Q2 2026, an estimated $341K.
  • Insmed made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1597 holding.
  • Cerity Partners first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Cerity Partners's Insmed position peaked at $3.51M in Q1 2026.
  • 609 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.